189 related articles for article (PubMed ID: 16478791)
21. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
[TBL] [Abstract][Full Text] [Related]
22. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin.
Jeon SH; Yoon JY; Park YN; Jeong WJ; Kim S; Jho EH; Surh YJ; Choi KY
J Biol Chem; 2007 May; 282(19):14482-92. PubMed ID: 17374607
[TBL] [Abstract][Full Text] [Related]
23. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
Nateri AS; Spencer-Dene B; Behrens A
Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
Hirota T; Irie K; Okamoto R; Ikeda W; Takai Y
Oncogene; 2005 Mar; 24(13):2229-35. PubMed ID: 15688018
[TBL] [Abstract][Full Text] [Related]
25. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
Kipp A; Banning A; Brigelius-Flohé R
Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
[TBL] [Abstract][Full Text] [Related]
26. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
28. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
[TBL] [Abstract][Full Text] [Related]
29. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
30. Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin.
Seo E; Jho EH
Biochem Biophys Res Commun; 2007 May; 357(1):81-6. PubMed ID: 17418091
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer and genetic alterations in the Wnt pathway.
Segditsas S; Tomlinson I
Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
33. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
34. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
35. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms.
Cho HJ; Kang JH; Kwak JY; Lee TS; Lee IS; Park NG; Nakajima H; Magae J; Chang YC
Carcinogenesis; 2007 May; 28(5):1104-10. PubMed ID: 17114644
[TBL] [Abstract][Full Text] [Related]
36. Regulatory mechanisms and function of ERK MAP kinases.
Torii S; Nakayama K; Yamamoto T; Nishida E
J Biochem; 2004 Nov; 136(5):557-61. PubMed ID: 15632293
[TBL] [Abstract][Full Text] [Related]
37. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.
Gujral TS; van Veelen W; Richardson DS; Myers SM; Meens JA; Acton DS; Duñach M; Elliott BE; Höppener JW; Mulligan LM
Cancer Res; 2008 Mar; 68(5):1338-46. PubMed ID: 18316596
[TBL] [Abstract][Full Text] [Related]
38. Wnt pathway mutations selected by optimal beta-catenin signaling for tumorigenesis.
Cho KH; Baek S; Sung MH
FEBS Lett; 2006 Jun; 580(15):3665-70. PubMed ID: 16764864
[TBL] [Abstract][Full Text] [Related]
39. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
40. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
